Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 181 - 200 of 509 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of KW-0761 or Standard Therapy in Patients with Previously Treated Adult T-Cell Leukemia-Lymphoma
[Protocol 12-251]
Horwitz, Steven
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
Relapsed/Refractory
[Protocol 12-170]
Horwitz, Steven
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
PDX-017: A Phase III Study of Pralatrexate Versus Observation in Patients with Peripheral T-Cell Lymphoma Following Initial Chemotherapy
Newly Diagnosed & Relapsed/Refractory
[Protocol 10-212]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Brentuximab Vedotin versus Standard Therapy in Patients with Cutaneous T-Cell Lymphoma
[Protocol 13-008]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study Comparing Different Types of Surgery to Treat Patients with Stage IA Non-Small Cell Lung Cancer
Newly Diagnosed
[Protocol 14-182]
Huang, James
  • Lung Cancer, Non-Small Cell
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038]
Huang, James
  • Thymoma
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
[Protocol 12-267]
Hudis, Clifford
  • Breast Cancer
  • Survivorship
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131]
Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma
  • Rare Blood Disorders
A Phase II Study of Dasatinib to Treat Recurrent Clear Cell Cancer of the Ovaries or Endometrium
[Protocol 14-008]
Hyman, David
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
A Phase I Study of AZD5363 in Patients with Solid Tumors Who Have AKT1 and PI3KCA Mutations
[Protocol 14-214]
Hyman, David
  • Solid Tumors
A Phase I Study of HDM201 in Patients with Advanced Cancers and a Normal TP53 Gene
[Protocol 14-139]
Hyman, David
  • Colorectal Cancer
  • Germ Cell Tumors
  • Hematology
    • Hematologic Malignancies
    • Myelodysplastic Syndrome
  • Kidney Cancer
  • Leukemia
  • Melanoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
  • Solid Tumors
A Phase I Study of MEDI3617 in Patients with Advanced Solid Tumors
[Protocol 11-052]
Hyman, David
  • Colorectal Cancer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of STM 434 in Patients with Ovarian Cancer and Other Advanced Solid Tumors
[Protocol 14-132]
Hyman, David
  • Ovarian Cancer
  • Solid Tumors
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2
[Protocol 13-140]
Hyman, David
  • Bladder Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
A Phase III Study of Standard Chemotherapy with and without Rilotumumab as Initial Treatment in Patients with Metastatic or Inoperable Gastric/Esophageal Cancer
[Protocol 13-091]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of FOLFOX plus Regorafenib in Patients with Inoperable or Metastatic Esophageal and/or Stomach Cancer
[Protocol 13-080]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
[Protocol 06-103]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Nintedanib in Patients with Advanced Esophagogastric Cancer
[Protocol 14-094]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer